11 September 2026
Evidence before argument: the saisie-contrefaçon, the French weapon foreign patent holders forget
10 September 2026
The launch letter before the UPC: what generics and biosimilars should write to avoid creating urgency
5 September 2026
Portfolio strategy and the UPC: where the value of life sciences assets lies
5 September 2026
Merz v. Viatris on appeal: urgency remains decisive, but not every signal is urgent
4 September 2026
UPC and life sciences: the first strategic lessons
4 September 2026
The UPC's long-arm jurisdiction: how far the arm reaches, where the effect stops
3 September 2026
Imminent infringement before the UPC: the new geography of pharmaceutical risk
3 September 2026
The PMAC Rules: patent arbitration through the FRAND lens
2 September 2026
The UPC did not end parallel litigation: it turned it into a weapon
2 September 2026
Acer v Nokia: the contractual turn of FRAND arbitration
1 September 2026
Damages before the UPC: from compensation to a market reference
1 September 2026
Tesla v InterDigital: the FRAND undertaking inside the patent pool
31 August 2026
Forum shopping before the UPC: the map, the language and Article 33
31 August 2026
FRAND licence: the prior question for standard essential patents
30 August 2026
Anti-anti-suit injunctions before the UPC: Europe strikes back
30 August 2026
UPC evidence preservation orders: the UPC saisie in practice
28 August 2026
The saisie conservatoire: obtaining evidence in France for foreign proceedings
28 August 2026
French saisie-contrefaçon or UPC seizure: the decision matrix
24 February 2025
The UPC's first FRAND decision: Panasonic v Oppo, and what came next
20 January 2025
Drawing up a confidentiality agreement: complete guide
30 July 2024
Sanofi v. Amgen: the UPC's first revocation action and therapeutic antibody patentability, from revocation to reversal
29 July 2024
Comparable licenses before the UPC: compelled production and confidentiality clubs
29 July 2024
UPC’s Order to Produce Evidence: Huawei vs. Netgear
22 July 2024
The UPC’s first ruling on an infringement action by the Paris local division
6 May 2024
UPC and Proportionality: Will the EU enters through the back door? (From 10xGenomics case to UPC “seizure”)
30 April 2024
Release of a treaty on patent law co-authored by Matthieu Dhenne
4 April 2024
UPC “seizure” Part IV: the appeal against the “seizure” order
22 March 2024
UPC “seizure” Part III: the “C-Kore” case
18 March 2024
UPC seizure Part II: the “OERLIKON” case
19 December 2023
FINGOLIMOD or the Blues of Hesitation: can preliminary injunctions be based on a patent application under French law?
25 July 2023
APIXABAN case in France: priority to the patent holder
5 June 2023
UPC: brief thoughts from a French “UPC Representative”
23 April 2023
Conflicts between UPCA and national laws: a dangerous riddle?
8 March 2023
Saisie-contrefaçon and trade secrets: protecting the seized party
1 March 2023
Some light for the sunrise: 5 questions for 5 French UPC judges
26 October 2020
PEMETREXED patent infringement in France: €28 million in damages for Eli Lilly (“France is back”?)